The Life Healthcare share price took a significant knock in early trade yesterday, falling by as much as 9%. This happened after the hospital group released a trading statement detailing a multi-billion Rand adjustment to its financial liabilities. Investors reacted...
High blood pressure, a condition traditionally associated with adults, is rapidly becoming a major health crisis for the younger generation. New research published in The Lancet Child & Adolescent Health reveals that the worldwide prevalence of hypertension in...
The Competition Commission has confirmed it is actively investigating the South African subsidiary of the Indian generic drug manufacturer Hetero. They are looking into potential price collusion. This significant probe centres on the procurement of crucial HIV...
Ascendis Health has confirmed its plan to delist from the JSE in the first week of December, following an overwhelming mandate from its investors. This decision marks the culmination of the company’s significant turnaround strategy. Not long ago, it faced the...
The South African subsidiary of Indian generic giant Hetero has launched an urgent legal attack against the Department of Health over its latest HIV/AIDS drug tender. Hetero SA alleges that authorities unlawfully excluded it from crucial contracts to supply the...
